Literature DB >> 12656704

Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.

Marcelo E Bigal1, Alan M Rapoport, Richard B Lipton, Stewart J Tepper, Fred D Sheftell.   

Abstract

BACKGROUND: Chronic migraine is the most common type of chronic daily headache seen in headache tertiary care centers. Most patients with chronic migraine report their ability to function and feeling of well-being as severely impaired.
OBJECTIVE: To measure the headache-related disability of patients with chronic migraine using the Migraine Disability Assessment (MIDAS) Questionnaire, comparing it with that obtained in a control group of patients with episodic migraine.
METHODS: The clinical records of 703 patients with chronic daily headache treated in a headache specialty clinic were reviewed to identify 182 with chronic migraine who were evaluated using the MIDAS at their initial visit. Our control group consisted of 86 patients with episodic migraine.
RESULTS: Of the 182 patients with chronic migraine, 127 (69.8%) were overusing acute-care medication. Patients were predominantly women (72.5%), with a mean age of 38.3 years. The group with episodic migraine consisted of 59 women (68.6%), with a mean age of 36.1 years. No statistically significant demographic differences were observed between the two groups. The group with chronic migraine had more total headache days over 3 months (66.7 versus 15.5, P<.001), missed more days of work or school (5.3 versus 2.3, P =.0007), had more reduced effectiveness days at work or school (11.9 versus 4.6, P =.0001), missed more days of housework (16.5 versus 3.3, P<.0001), and missed more days of family, social, or leisure activities (7.0 versus 5.5, P =.03). The group with chronic migraine was more likely to be in MIDAS grade IV (64.3% versus 43.2%, P =.001), reflecting the great likelihood of severe disability in this group. The average total MIDAS score was 34.9 in the group with chronic migraine versus 19.3 in the group with episodic migraine (P<.001).
CONCLUSION: In subspecialty centers, patients with chronic migraine demonstrate remarkable impairment of their daily activities and are severely burdened by their headache syndrome, reflected by their high MIDAS scores. The chronicity and pervasiveness of migraine thus is associated with increased functional impairment as well as increase in headache frequency.

Entities:  

Mesh:

Year:  2003        PMID: 12656704     DOI: 10.1046/j.1526-4610.2003.03068.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  64 in total

1.  Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse.

Authors:  Alberto Raggi; Ambra Mara Giovannetti; Silvia Schiavolin; Matilde Leonardi; Gennaro Bussone; Licia Grazzi; Susanna Usai; Marcella Curone; Paola Di Fiore; Domenico D'Amico
Journal:  Qual Life Res       Date:  2013-10-16       Impact factor: 4.147

Review 2.  Disability in chronic daily headache: state of the art and future directions.

Authors:  Domenico D'Amico; L Grazzi; S Usai; A Raggi; M Leonardi; G Bussone
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 3.  Are Episodic and Chronic Migraine One Disease or Two?

Authors:  Reuben Burshtein; Aaron Burshtein; Joshua Burshtein; Noah Rosen
Journal:  Curr Pain Headache Rep       Date:  2015-12

4.  Occipital nerve stimulation for chronic migraine.

Authors:  William B Young
Journal:  Curr Pain Headache Rep       Date:  2014-02

Review 5.  Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.

Authors:  Melissa T Stone; Valerie Weed; Ronald J Kulich
Journal:  Curr Pain Headache Rep       Date:  2016-09

Review 6.  Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review.

Authors:  A Raggi; V Covelli; M Leonardi; L Grazzi; M Curone; D D'Amico
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

7.  Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot study.

Authors:  Alan M Rapoport; Fred D Sheftell; Stewart J Tepper; Marcelo E Bigal
Journal:  Curr Ther Res Clin Exp       Date:  2005-05

Review 8.  Estrogen and chronic daily headache.

Authors:  Dawn A Marcus
Journal:  Curr Pain Headache Rep       Date:  2004-02

9.  The social impact of dizziness in London and Siena.

Authors:  Adolfo M Bronstein; John F Golding; Michael A Gresty; Marco Mandalà; Daniele Nuti; Anu Shetye; Yvonne Silove
Journal:  J Neurol       Date:  2009-08-22       Impact factor: 4.849

10.  Prevalence and characteristics of allodynia in headache sufferers: a population study.

Authors:  M E Bigal; S Ashina; R Burstein; M L Reed; D Buse; D Serrano; R B Lipton
Journal:  Neurology       Date:  2008-04-22       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.